Wednesday, 14 Oct 2020 11:43 PM MYTPUTRAJAYA, Oct 14 — Two metformin products which have been recalled from the market by its manufacturer, Marksans Pharma Limited, are not registered in Malaysia and not supplied to the health facilities in the country.
“A total of 68 metformin products registered with the DCA and available in the Malaysian market, have undergone the N-Nitrosodimethylamine impurity testing. Dr Faridah Aryani said the ministry’s National Pharmaceutical Regulatory Agency would recall the metformin products from the market if they have NDMA impurities that exceed the limit.
On October 9, CNN Health reported that two metformin products used for diabetic patients were recalled after manufacturers found it contained unacceptably high levels of a cancer-causing agent and the NDMA had exceeded the internationally acceptable level.